Search results for "Stroke"
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023
MKSAP Quiz: 2-year history of worsening hot flashes
A 56-year-old woman is evaluated for a 2-year history of worsening hot flashes and night sweats. She reports that the night sweats awaken her several times nightly, resulting in fatigue and missed work. Following a physical exam, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2022/12/20/3.htm
20 Dec 2022
MKSAP Quiz: Follow-up for diabetes, hyperlipidemia, hypertension
A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2022/11/15/3.htm
15 Nov 2022
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
BiPAP machines, masks recalled
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/11/bipap-machines-masks-recalled.htm
1 Nov 2022
Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds
Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022
New trials provide data to improve medication management in hypertension
A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.
https://immattersacp.org/weekly/archives/2022/10/18/6.htm
18 Oct 2022
MKSAP Quiz: Follow-up visit for chronic hypertension
A 44-year-old woman is evaluated during a follow-up visit for chronic hypertension. Over the past month, her average blood pressure measured with home blood pressure monitoring was 150/90 mm Hg. Following a physical exam and lab tests, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2022/10/11/3.htm
11 Oct 2022
Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find
A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://immattersacp.org/weekly/archives/2022/09/27/4.htm
27 Sep 2022